Santa Monica, CALIFORNIA4 Active Studies

Stomach Cancer Clinical Trials in Santa Monica, CALIFORNIA

Find 4 actively recruiting stomach cancer clinical trials in Santa Monica, CALIFORNIA. Connect with local research sites and explore new treatment options.

4
Active Trials
3
Sponsors
1,579
Enrolling

Recruiting Stomach Cancer Studies in Santa Monica

RecruitingSanta Monica, CALIFORNIANCT06764875

A Phase â…¢ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer

This is a Phase â…¢, randomized, open-label, Sponsor-blinded, 3-arm, global, multicenter study assessing the efficacy and safety of rilvegostomig in combination with fluoropyrimidine and T-DXd (Arm A) c...

840 participants
AstraZeneca
View Study Details
RecruitingSanta Monica, CALIFORNIANCT04379596

Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03)

DESTINY-Gastric03 will investigate the safety, tolerability, pharmacokinetics, immunogenicity, and preliminary antitumor activity of trastuzumab deruxtecan (T-DXd) alone or in combination with chemoth...

413 participants
AstraZeneca
View Study Details
RecruitingSanta Monica, CALIFORNIANCT06628310

A Study to Evaluate the Adverse Events, Efficacy, and Optimal Dose of Intravenous (IV) ABBV-400 in Combination With IV Fluorouracil, Leucovorin, and Budigalimab in Adult Participants With Locally Advanced Unresectable or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma

Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. The purpose of this study is to assess adverse events and change in disease activity when ABBV-400 is gi...

180 participants
AbbVie
View Study Details
RecruitingSanta Monica, CALIFORNIANCT06038578

A Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer

This study will assess the efficacy, safety, optimal dose and ADA and NAbs development of TRK-950 at two separate dose levels in combination with ramucirumab and paclitaxel (RAM+PTX) as compared with ...

146 participants
Toray Industries, Inc
View Study Details

About Stomach Cancer Clinical Trials in Santa Monica

Stomach (gastric) cancer develops in the lining of the stomach and is more common in certain regions of the world. Risk factors include H. pylori infection, smoking, and diet. Treatment includes surgery, chemotherapy, radiation, and immunotherapy.

There are currently 4 stomach cancer clinical trials recruiting participants in Santa Monica, CALIFORNIA. These studies are seeking a combined 1,579 participants. Research is being sponsored by AstraZeneca, AbbVie, Toray Industries, Inc. Clinical trial participation is free and participants receive study-related medical care at no cost.

Stomach Cancer Clinical Trials in Santa Monica — FAQ

Are there stomach cancer clinical trials in Santa Monica?

Yes, there are 4 stomach cancer clinical trials currently recruiting in Santa Monica, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Santa Monica?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Santa Monica research site will contact you about next steps.

Are clinical trials in Santa Monica free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Santa Monica studies also compensate for your time and travel.

What stomach cancer treatments are being tested?

The 4 active trials in Santa Monica are testing new therapies including novel drugs, biologics, and treatment approaches for stomach cancer.

Data updated March 2, 2026 from ClinicalTrials.gov